Nukkleus Inc. (NASDAQ:NUKK – Get Free Report) insider Anastasiia Kotaieva sold 75,000 shares of the firm’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $4.09, for a total value of $306,750.00. Following the completion of the sale, the insider directly owned 75,000 shares in the company, valued at $306,750. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Anastasiia Kotaieva also recently made the following trade(s):
- On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.26, for a total value of $236,873.04.
- On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
- On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.57, for a total value of $319,900.00.
- On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The shares were sold at an average price of $4.41, for a total value of $132,300.00.
- On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total value of $317,100.00.
- On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total transaction of $182,871.68.
Nukkleus Price Performance
Shares of NASDAQ NUKK remained flat at $4.03 during mid-day trading on Wednesday. 836,808 shares of the stock were exchanged, compared to its average volume of 1,723,410. The stock has a market cap of $67.10 million, a PE ratio of 0.25 and a beta of -6.75. The stock has a 50 day moving average of $5.68 and a 200 day moving average of $6.79. Nukkleus Inc. has a 52 week low of $3.31 and a 52 week high of $40.98.
Institutional Inflows and Outflows
Analysts Set New Price Targets
NUKK has been the subject of several research reports. Wall Street Zen raised shares of Nukkleus from a “sell” rating to a “hold” rating in a research report on Sunday, November 23rd. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Nukkleus has a consensus rating of “Sell”.
Get Our Latest Stock Report on NUKK
Nukkleus News Roundup
Here are the key news stories impacting Nukkleus this week:
- Positive Sentiment: Completed acquisition of Israeli defense software firm Tiltan — adds ~30 years of defense AI experience and supplier relationships with IAI, Elbit and Rafael; the deal (via Israeli subsidiary Nukk Picolo Ltd.) could strengthen Nukkleus’s product/service offering and government/defense revenue pipeline. Nukkleus Completes Tiltan Acquisition, Adds 30 Years of Defense AI Leadership to Portfolio
- Neutral Sentiment: Press coverage and summaries of the Tiltan deal (additional reads). Confirms the completion but contains little new operational detail beyond the press release. Nukkleus Completes Acquisition of Israeli Software Firm Tiltan
- Negative Sentiment: Insider sale — Anastasiia Kotaieva sold 30,000 shares on Dec. 22 at an average $4.41 (≈$132,300); sale reduced her stake by ~2.20%. SEC Filing
- Negative Sentiment: Insider sale — Anastasiia Kotaieva sold 70,000 shares on Dec. 23 at an average $4.57 (≈$319,900); sale reduced her stake by ~5.26%. SEC Filing
- Negative Sentiment: Insider sale — Anastasiia Kotaieva sold 55,604 shares on Dec. 24 at an average $4.49 (≈$249,662); sale reduced her stake by ~4.41%. SEC Filing
- Negative Sentiment: Insider sale — Anastasiia Kotaieva sold 55,604 shares on Dec. 26 at an average $4.26 (≈$236,873); sale reduced her position by ~4.61%. Despite these sales, she remains a large holder (over 1M shares). SEC Filing
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
See Also
- Five stocks we like better than Nukkleus
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
